Actively Recruiting
Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
Led by University of Regensburg · Updated on 2022-08-23
250
Participants Needed
2
Research Sites
613 weeks
Total Duration
On this page
Sponsors
U
University of Regensburg
Lead Sponsor
K
Krankenhaus Barmherzige Brüder, Regensburg
Collaborating Sponsor
AI-Summary
What this Trial Is About
Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses
CONDITIONS
Official Title
Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Suspicious peritoneal carcinomatosis
You will not qualify if you...
- Younger than 18 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Krankenhaus der Barmherzigen Brüder Regensburg
Regensburg, Bavaria, Germany, 93049
Not Yet Recruiting
2
University Hospital Regensburg
Regensburg, Germany, 93053
Actively Recruiting
Research Team
J
Jens M Werner, MD
CONTACT
M
Monika Diehl-Bein
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here